Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juliana Benito

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 9, 2007
PDP1epsilon functions downstream of the circadian oscillator to mediate behavioral rhythmsJuliana Benito, Hao Zheng, Paul E Hardin
International Journal of Hematologic Oncology|February 4, 2014
Targeting hypoxia in the leukemia microenvironmentJuliana Benito, Zhihong Zeng, Marina Konopleva, et al.
Journal of Biological Rhythms|July 30, 2008
The blue-light photoreceptor CRYPTOCHROME is expressed in a subset of circadian oscillator neurons in the Drosophila CNSJuliana Benito, Jerry H Houl, Gregg W Roman, et al.
Folia Microbiologica|October 27, 2014
Phylogenentic and enzymatic characterization of psychrophilic and psychrotolerant marine bacteria belong to γ-Proteobacteria group isolated from the sub-Antarctic Beagle Channel, ArgentinaHéctor A Cristóbal, Juliana Benito, Gustavo A Lovrich, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
The circadian output gene takeout is regulated by Pdp1epsilonJuliana Benito, Valbona Hoxha, Chamala Lama, et al.
British Journal of Haematology|June 20, 2014
SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemiaOlga Frolova, Juliana Benito, Chris Brooks, et al.
Oncotarget|October 17, 2015
The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM inhibitor AZD1208 inhibits growth in acute myeloid leukemia via HSF pathway suppressionMasako Harada, Juliana Benito, Shinichi Yamamoto, et al.
Science Translational Medicine|April 2, 2025
Self-regulating gene therapy ameliorates phenotypes and overcomes gene dosage sensitivity in a mouse model of Rett syndromePaul D Ross, Kamal K E Gadalla, Sophie R Thomson, et al.
Molecular Therapy. Nucleic Acids|July 2, 2026
Neonatal expression of human FMRP isoform corrects cortical deficits and improves behavior in a mouse model of fragile X syndromeAnna O Norman, Courtney Scaramella, Dominik Biezonski, et al.
Plos One|August 20, 2011
Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104Juliana Benito, Yuexi Shi, Barbara Szymanska, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 9, 2007
PDP1epsilon functions downstream of the circadian oscillator to mediate behavioral rhythmsJuliana Benito, Hao Zheng, Paul E Hardin
International Journal of Hematologic Oncology|February 4, 2014
Targeting hypoxia in the leukemia microenvironmentJuliana Benito, Zhihong Zeng, Marina Konopleva, et al.
Journal of Biological Rhythms|July 30, 2008
The blue-light photoreceptor CRYPTOCHROME is expressed in a subset of circadian oscillator neurons in the Drosophila CNSJuliana Benito, Jerry H Houl, Gregg W Roman, et al.
Folia Microbiologica|October 27, 2014
Phylogenentic and enzymatic characterization of psychrophilic and psychrotolerant marine bacteria belong to γ-Proteobacteria group isolated from the sub-Antarctic Beagle Channel, ArgentinaHéctor A Cristóbal, Juliana Benito, Gustavo A Lovrich, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
The circadian output gene takeout is regulated by Pdp1epsilonJuliana Benito, Valbona Hoxha, Chamala Lama, et al.
British Journal of Haematology|June 20, 2014
SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemiaOlga Frolova, Juliana Benito, Chris Brooks, et al.
Oncotarget|October 17, 2015
The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM inhibitor AZD1208 inhibits growth in acute myeloid leukemia via HSF pathway suppressionMasako Harada, Juliana Benito, Shinichi Yamamoto, et al.
Science Translational Medicine|April 2, 2025
Self-regulating gene therapy ameliorates phenotypes and overcomes gene dosage sensitivity in a mouse model of Rett syndromePaul D Ross, Kamal K E Gadalla, Sophie R Thomson, et al.
Molecular Therapy. Nucleic Acids|July 2, 2026
Neonatal expression of human FMRP isoform corrects cortical deficits and improves behavior in a mouse model of fragile X syndromeAnna O Norman, Courtney Scaramella, Dominik Biezonski, et al.
Plos One|August 20, 2011
Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104Juliana Benito, Yuexi Shi, Barbara Szymanska, et al.
Pageof 2